Manganese poisoning
disease diseaseOn this page
Also known as manganese intoxicationManganism
Summary
Manganese poisoning (MONDO:0017638) is a disease. A subtype of toxic encephalopathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Phenotypes (HPO): 30
Clinical features
Signs & symptoms
Clinical features (HPO)
30 HPO clinical features (Orphanet curated; top 30 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000712 | Emotional lability | Very frequent (80-99%) |
| HP:0001276 | Hypertonia | Very frequent (80-99%) |
| HP:0001288 | Gait disturbance | Very frequent (80-99%) |
| HP:0001332 | Dystonia | Very frequent (80-99%) |
| HP:0002067 | Bradykinesia | Very frequent (80-99%) |
| HP:0002071 | Abnormality of extrapyramidal motor function | Very frequent (80-99%) |
| HP:0002172 | Postural instability | Very frequent (80-99%) |
| HP:0002174 | Postural tremor | Very frequent (80-99%) |
| HP:0002315 | Headache | Very frequent (80-99%) |
| HP:0002354 | Memory impairment | Very frequent (80-99%) |
| HP:0002396 | Cogwheel rigidity | Very frequent (80-99%) |
| HP:0002453 | Abnormal globus pallidus morphology | Very frequent (80-99%) |
| HP:0003287 | Abnormality of mitochondrial metabolism | Very frequent (80-99%) |
| HP:0006979 | Sleep-wake cycle disturbance | Very frequent (80-99%) |
| HP:0025464 | Increased reactive oxygen species production | Very frequent (80-99%) |
| HP:0000505 | Visual impairment | Frequent (30-79%) |
| HP:0000718 | Aggressive behavior | Frequent (30-79%) |
| HP:0000722 | Compulsive behaviors | Frequent (30-79%) |
| HP:0000746 | Delusion | Frequent (30-79%) |
| HP:0000748 | Inappropriate laughter | Frequent (30-79%) |
| HP:0000802 | Impotence | Frequent (30-79%) |
| HP:0001289 | Confusion | Frequent (30-79%) |
| HP:0002304 | Akinesia | Frequent (30-79%) |
| HP:0030018 | Decreased female libido | Frequent (30-79%) |
| HP:0040306 | Decreased male libido | Frequent (30-79%) |
| HP:0000716 | Depression | Occasional (5-29%) |
| HP:0000737 | Irritability | Occasional (5-29%) |
| HP:0000738 | Hallucinations | Occasional (5-29%) |
| HP:0031466 | Impairment in personality functioning | Occasional (5-29%) |
| HP:5200321 | Amplification of sexual behavior | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | manganese poisoning |
| Mondo ID | MONDO:0017638 |
| EFO | EFO:1001808 |
| MeSH | D020149 |
| Orphanet | 306682 |
| SNOMED CT | 88687001 |
| GARD | 0021264 |
| MedDRA | 10058951 |
| Is cancer (heuristic) | no |
Also known as: manganese intoxication · Manganism
Disease family
This is a subtype of toxic encephalopathy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › toxic encephalopathy › manganese poisoning
Related subtypes (4): hepatic encephalopathy, carbon monoxide-induced delayed encephalopathy, Minamata disease, chronic bilirubin encephalopathy
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.